INHA and tuberculosis: Factors which may have contributed to a favourable outcome in this cohort include, the majority of patients with INH monoresistance were new cases of tuberculosis and had low-level INH resistance causing mutations (in the inhA promoter; MIC range, 0.2–1 mg/L [18]).